Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × mCRC × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 2 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 3203 Carcinoma, Non-Small-Cell Lung 2705 Breast Neoplasms 2533 Colorectal Neoplasms 1444 Prostatic Neoplasms 1291 Neoplasm Metastasis 1286 Multiple Myeloma 1100 Melanoma 1098 Ovarian Neoplasms 998 Lung Neoplasms 938 Recurrence 915 Leukemia, Myeloid, Acute 872 Pancreatic Neoplasms 823 Lymphoma, Non-Hodgkin 762 Lymphoma 710 Stomach Neoplasms 686 Carcinoma, Renal Cell 655 Carcinoma, Hepatocellular 640 Leukemia, Lymphocytic, Chronic, B-Cell 556 Squamous Cell Carcinoma of Head and Neck 544 Lymphoma, Follicular 510 Head and Neck Neoplasms 486 Glioblastoma 470 Lymphoma, Large B-Cell, Diffuse 439 Small Cell Lung Carcinoma 438 Triple Negative Breast Neoplasms 431 Leukemia 422 Advanced Solid Tumors 420 Uterine Cervical Neoplasms 418 Urinary Bladder Neoplasms 404

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07543471 2026-04-21

PK equivalence

Shanghai Henlius Biotech

Phase 1 Not yet recruiting

mCRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡